Showing Results for
- Academic Journals (15)
Search Results
- 15
Academic Journals
- 15
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Sarah F Adams aff1 , Fabian Benencia [*] aff2 KEYWORDS chemotherapy; immunotherapy; ovarian cancer; tumor microenvironment Ovarian cancer Epithelial ovarian cancer affects approximately one in 70...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Julie R Brahmer [*] aff1 , Hans Hammers aff1 , Evan J Lipson aff1 KEYWORDS immune checkpoint inhibitors; immunotherapy; lung cancer; melanoma; nivolumab; PD-1; programmed death-1; renal cancer The...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Michele Del Vecchio [*] aff1 , Paolo Antonio Ascierto aff2 , Mario Mandalà aff3 , Vanna Chiarion Sileni aff4 , Michele Maio aff5 , Lorenza Di Guardo aff1 , Ester Simeone aff2 , Paola Queirolo aff6 KEYWORDS...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedABSTRACT Rituximab is a type I anti-CD20 monoclonal antibody, which stabilizes CD20 on lipid rafts, promoting antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity activities. It is the first...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Niloy Ranjan Datta [*] aff1 aff2 , Shalini Singh aff1 , Piyush Kumar aff1 aff3 , Dinesh Gupta aff4 KEYWORDS apoptosis; cervical cancer; HPV; p53; pRb; radiation dose-response; radiation therapy;...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Omar Abdel-Rahman [*] KEYWORDS brivanib; FGFR; gastrointestinal cancer; regorafenib Colorectal cancer (CRC) is a major cause of cancer-related morbidity and mortality worldwide; it is considered as...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Andreas H Mahnken [*] KEYWORDS HCC; liver; neoplasm; metastasis; radioembolization Primary and secondary liver malignancies are common manifestations of solid tumors. While hepatocellular carcinoma...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Masakazu Toi [*] aff1 , Eric P Winer aff2 , John R Benson aff3 , Takashi Inamoto aff4 , John F Forbes aff5 , Gunter von Minckwitz aff6 , John FR Robertson aff7 , Stephen R Grobmyer aff8 , Ismail Jatoi aff9 ,...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): David M Liu [*] aff1 , Avnesh S Thakor aff2 , Mark Baerlocher aff3 , Mohammed T Alshammari aff1 , Howard Lim aff4 , Sebastian Kos aff5 , Andrew S Kennedy aff6 , Harpreet Wasan aff7 KEYWORDS colon cancer...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Masakazu Toi [*] aff1 , Eric P Winer aff2 , John R Benson aff3 , Takashi Inamoto aff4 , John F Forbes aff5 , Gunter von Minckwitz aff6 , John FR Robertson aff7 , Stephen R Grobmyer aff8 , Ismail Jatoi aff9 ,...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Chiara Ciccarese aff1 , Matteo Santoni aff2 , Francesco Massari aff1 , Liang Cheng aff3 , Antonio Lopez-Beltran aff4 , Marina Scarpelli aff5 , Alessandro Conti aff6 , Giampaolo Tortora aff1 , Stefano Cascinu...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Maira Zorzan aff1 , Enrico Giordan aff1 , Marco Redaelli aff1 aff2 , Antonio Caretta aff2 aff3 , Carla Mucignat-Caretta [*] aff1 aff2 KEYWORDS diagnosis; glioblastoma; intracellular pathways; signaling;...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Piergiacomo Calzavara Pinton aff1 , Lisa Licitra aff2 , Katia Peris aff3 , Armando Santoro aff4 , Paolo Antonio Ascierto [*] aff5 KEYWORDS adverse events; basal cell carcinoma; clinical practice;...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Ioannis Gounaris [*] aff1 , James D Brenton aff1 KEYWORDS ARID1A; endometriosis; genetically engineered mouse models; glycogen; HNF1B; ovarian clear; PIK3CA cell cancer Origins of epithelial ovarian...
-
From:Future Oncology (Vol. 11, Issue 9) Peer-ReviewedAuthor(s): Chiara Ciccarese aff1 , Alessandra Modena aff1 , Giampaolo Tortora aff1 , Francesco Massari [*] aff1 KEYWORDS metastatic renal cell carcinoma; targeted agents 2014 has certainly been the year of...